Identification of a DNA damage repair-related LncRNA signature for predicting the prognosis and immunotherapy response of hepatocellular carcinoma.

Authors:
Huang F; Zhang C; Yang W; Zhou Y; Yang Y and 3 more

Journal:
BMC Genomics

Publication Year: 2024

DOI:
10.1186/s12864-024-10055-1

PMCID:
PMC10851502

PMID:
38326754

Journal Information

Full Title: BMC Genomics

Abbreviation: BMC Genomics

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Genetics

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateApproval for the use of human subjects was obtained from the Research Ethics Committee of Zhongshan Hospital (B2022-435R). Informed consent was obtained from each individuals. Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding This work was supported by the Zhongshan Hospital Fudan University (2021ZSQN37 and 2020ZSLC54); Natural Science Foundation of China (82172348 and 82102483); Key Medical and Health Projects of Xiamen (YDZX20193502000002); Shanghai Baoshan Medical Key Specialty (BSZK2023A18); Shanghai Key Clinical Specialty Construction Project (shslczdzk03302)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025